Immunaeon: Funding, Investors & Team (Sep 2026)
Immunaeon offers a service that involves storing immune cells in order to safeguard individuals from contracting a host of different diseases. The company employs advanced medical technology to ensure that its patients enjoy long and healthy lives, by extracting, analyzing, preserving, and shielding healthy immune cells that play a crucial role in shielding against viruses, infections, autoimmune diseases, bacterial infections, and cancer.
Immunaeon has raised $600k across 1 funding round on record, the most recent a Seed of $600k announced in Apr 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Immunaeon Company Profile and Key Stats
Latest funding round on record: Apr 2023.
Immunaeon Funding Rounds
Immunaeon Founders and Leadership Team
Contact details for the Immunaeon team: 1 of 1 has an email address on file.
Start 14-day free trial →Immunaeon Funding Compared to Other Biotechnology Startups
Immunaeon's latest round of $600k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Immunaeon in Biotechnology and Buffalo
Companies Similar to Immunaeon
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Immunaeon Funding FAQs
What does Immunaeon do?
Immunaeon offers a service that involves storing immune cells in order to safeguard individuals from contracting a host of different diseases. The company employs advanced medical technology to ensure that its patients enjoy long and healthy lives, by extracting, analyzing, preserving, and shielding healthy immune cells that play a crucial role in shielding against viruses, infections, autoimmune diseases, bacterial infections, and cancer.
How much funding has Immunaeon raised?
Immunaeon has raised $600k across 1 round on record. The most recent is a Seed of $600k announced in Apr 2023.
When did Immunaeon last raise funding?
Immunaeon's most recent funding round on record is a Seed of $600k, announced in Apr 2023.
Who is the CEO of Immunaeon?
Adam Utley is listed as CEO at Immunaeon.
Where is Immunaeon headquartered?
Immunaeon is based in Buffalo, New York, United States.
How many employees does Immunaeon have?
Immunaeon is in the 1-10 employee band.
How does Immunaeon's funding compare to other Biotechnology startups?
Immunaeon's latest round of $600k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Immunaeon Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Immunaeon is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.